Stratistics MRC에 따르면 아스코르브산 세계 시장은 2025년에 17억 1,000만 달러, 예측 기간 동안 CAGR 7.2%로 성장하여 2032년에는 27억 9,000만 달러에 이를 것으로 예측됩니다.
인간의 건강에 필수적인 수용성 비타민은 아스코르브산이며, 비타민 C라고도합니다. 음식, 보충제에서 섭취해야합니다. 피망, 오렌지, 딸기와 같은 과일 및 채소에 포함 된 아스코르브산은 철분의 흡수를 촉진하고 면역 체계의 성능을 높이기 위해 건강 전반에 필수적입니다.
CXO에 따르면, 식품용 아스코르브산 수요는 매년 약 5% 증가하고 있기 때문에 아스코르브산의 새로운 제조 공정의 도입에 의해 수급 격차를 줄일 것으로 예상됩니다.
기능성 식품 및 식품 및 식품 성장
아스코르브산은 면역 증강 작용과 항산화 작용이 있기 때문에 일반적인 성분이며, 소비자는 기본적인 영양 보급에 그치지 않는 건강상의 이점을 제공하는 상품을 요구하고 있습니다. 비타민 C는 특히 면역 및 웰니스 카테고리에서 기능성 음료의 매력과 효과를 높이기 위해 매우 필요합니다. 소비자가 예방과 건강을 중시하게 된 결과, 제조업체는 제품의 배합에 아스코르브산을 더하게 되어 있습니다.
원료 가격 변동
솔비톨과 옥수수 등 필수적인 투입 자재의 가격이 정기적으로 변동하기 때문에 예산 편성이나 공급 체인 계획에 지장을 초래합니다. 많은 비용이 증가하기 때문에 특히 위험이 높습니다. 장기 계약이나 고객과의 관계도 일관성없는 가격 설정에 의해 영향을받을 수 있습니다.
신흥국 수요 증가
의약품과 영양보조식품에 비타민C가 사용되게 된 것은 도시화의 진전과 의료시설의 충실한 결과입니다. 브라질, 중국, 인도와 같은 국가에서 식품 가공 산업이 성장함에 따라 항산화제 및 방부제로서 아스코르브산의 사용도 증가하고 있습니다. 영양에 관한 지식을 높이는 정부의 프로그램도, 시장 확대에 공헌하고 있습니다.
위조품 및 규격 외품
조악한 제품이나 위조품은 종종 안전성과 유효성 요구 사항을 충족하지 못하고 소비자의 건강을 위협하고 경우에 따라 법적 문제로 발전 할 수 있습니다. 이에 따라 규제 기관은 더 엄격한 지침을 부과하여 적절한 기업의 규정 준수 비용을 높일 수 있습니다.
COVID-19의 영향
COVID-19의 팬데믹은 그 면역 강화 특성에 의한 수요 증가를 촉진하고, 아스코르브산 시장에 큰 영향을 주었습니다. 수요 부족이 생산과 유통을 방해했습니다. 시장이 순응함에 따라 제조업체는 수요 증가에 대응하기 위해 생산량을 확대했습니다.
예측 기간 동안 합성 부문이 최대가 될 전망
합성 부문은 비용 효율적이고 확장 가능한 생산 공정이므로 예측 기간 동안 최대 시장 점유율을 차지할 것으로 예측됩니다. 합성 아스코르브산은 일관된 순도와 안정성을 보장하여 산업용으로 적합합니다.
블리스터팩 분야는 예측기간 중 가장 높은 CAGR이 예상
예측기간 중 블리스터팩 분야는 습기나 공기로부터 효과적으로 보호함으로써 제품의 안정성을 높이고 보존기간을 연장함으로써 가장 높은 성장률을 보일 것으로 예측됩니다. 또한, 블리스터 포장은 정확한 투여와 내 탬퍼성을 보장하고, 아스코르브산 제품에 대한 소비자의 신뢰를 높입니다.
예측기간 중 인구 증가, 도시화, 의약품·식품가공산업 확대로 아시아태평양이 최대 시장 점유율을 차지할 것으로 예측됩니다. 건강상의 이점과 예방의료에 대한 소비자의 의식의 고조가 소비 확대의 원동력이 되고 있습니다. 중국과 인도는 대규모 생산 능력과 국내 수요 증가로 주요 공헌국이 되고 있습니다. 이 시장 특징은 비용 효율적인 제조 및 수출 확대입니다. 또한, 영양과 건강을 촉진하는 정부의 이니셔티브이 성장을 더욱 자극하고 아시아태평양은 세계의 아스코르브산 시장에서 가장 급성장하고 있는 지역의 하나가 되고 있습니다.
예측 기간 동안 북미는 특히 항산화 특성과 비타민 보조 식품 역할로 음식 섹터 수요가 증가하고 가장 높은 CAGR을 나타낼 것으로 예측됩니다. 건강 지향 증가와 영양 보조 식품 산업의 확대가 시장 성장에 기여하고 있습니다. 주요 기업은 엄격한 규제에 대응하기 위해 기술 혁신과 지속 가능한 생산 방법에 주력하고 있습니다. 제약 산업과 화장품 업계도 수요를 뒷받침하고 있습니다. 확립된 공급망과 첨단 제조 시설을 갖춘 북미는 천연 소재와 영양 강화 제품에 대한 소비자의 취향에 힘입어 안정적인 시장 궤도를 유지하고 있습니다.
According to Stratistics MRC, the Global Ascorbic Acid Market is accounted for $1.71 billion in 2025 and is expected to reach $2.79 billion by 2032 growing at a CAGR of 7.2% during the forecast period. A water-soluble vitamin that is vital to human health is ascorbic acid, also referred to as vitamin C. As a potent antioxidant, it shields cells from harm brought on by free radicals. It is essential for wound healing, collagen synthesis, and the preservation of strong bones, cartilage, and skin. Ascorbic acid must be obtained through diet or supplements because humans are unable to make it naturally. Ascorbic acid, which is present in fruits and vegetables such as bell peppers, oranges, and strawberries, is essential for overall health since it boosts iron absorption and immune system performance.
According to CXOs, the introduction of a new production process for ascorbic acid is expected to close down the demand and supply gap, as every year the demand for food-grade ascorbic acid rises by ~5%.
Growth in functional foods and beverages
Ascorbic acid is a common ingredient because of its immune-boosting and antioxidant qualities, and consumers are looking for goods that provide health advantages beyond basic nutrition. Because of its well-established health benefits, ascorbic acid is frequently used to fortify beverages, snacks, and supplements. Vitamin C is very necessary for functional beverages to increase their attractiveness and effectiveness, particularly in the immunity and wellness categories. Manufacturers are adding more ascorbic acid to product formulations as a result of consumers' increased emphasis on prevention and health. Consequently, one of the main factors propelling the expansion of the worldwide ascorbic acid market is the trend towards functional foods and beverages.
Raw material price volatility
Regular changes in the cost of essential inputs, such as sorbitol and maize, interfere with budgeting and supply chain planning. These ambiguities have the potential to lower profit margins and deter investment in expanding production. Small and mid-sized businesses are particularly at risk since they frequently can't keep up with unexpected expense rises. Long-term agreements and client relationships may also be impacted by inconsistent pricing. In general, market stability is compromised and growth is slowed by volatility.
Rising demand in emerging economies
Increased use of vitamin C in medications and nutritional supplements is a result of growing urbanisation and better healthcare facilities. The demand for fortified foods and beverages is being driven by growing middle-class populations that are growing more health conscious. Growing food processing industries in nations like Brazil, China, and India also lead to a rise in the use of ascorbic acid as an antioxidant and preservative. Government programs that raise knowledge of nutrition also help the market expand. All things considered, these elements contribute to the high and ongoing need for ascorbic acid in emerging nations.
Counterfeit and substandard products
Products that are subpar and counterfeit frequently fall short of safety and effectiveness requirements, endangering consumer health and perhaps resulting in legal repercussions. Because of price undercutting caused by their dissemination, it is more difficult for legitimate firms to engage in fair competition. In response, regulatory agencies might impose more stringent guidelines, raising the cost of compliance for respectable businesses. The reputation of reliable providers' brands is also harmed by the existence of counterfeit goods. In the end, this hinders market expansion generally and deters investment in new product development.
Covid-19 Impact
The Covid-19 pandemic significantly impacted the ascorbic acid market by driving increased demand due to its immune-boosting properties. Consumers and healthcare sectors prioritized vitamin C for prevention and recovery, boosting sales. However, supply chain disruptions and raw material shortages initially hindered production and distribution. As the market adapted, manufacturers scaled up output to meet rising demand. Overall, the pandemic accelerated awareness and consumption of ascorbic acid, positively influencing market growth despite early challenges.
The synthetic segment is expected to be the largest during the forecast period
The synthetic segment is expected to account for the largest market share during the forecast period, due to its cost-effective and scalable production process. It enables mass manufacturing to meet growing demand across industries like food, pharmaceuticals, and cosmetics. Synthetic ascorbic acid ensures consistent purity and stability, making it preferable for industrial applications. It also supports longer shelf life and better formulation compatibility in processed products. Additionally, ongoing innovations in synthetic production methods help lower costs, further boosting market adoption.
The blister packs segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the blister packs segment is predicted to witness the highest growth rate by enhancing product stability and extending shelf life through effective protection from moisture and air. These packs offer convenient, single-dose packaging, increasing consumer preference for vitamins and supplements, especially in the pharmaceutical and nutraceutical sectors. Blister packaging also ensures accurate dosing and tamper resistance, boosting consumer confidence in ascorbic acid products. Its cost-effective and scalable nature appeals to manufacturers looking to improve packaging efficiency. Moreover, the visually appealing presentation of blister packs helps drive retail sales, further supporting market growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising population, urbanization, and expanding pharmaceutical and food processing industries. Increasing consumer awareness about health benefits and preventive healthcare is driving higher consumption. China and India are major contributors due to their large-scale production capabilities and growing domestic demand. The market is characterized by cost-effective manufacturing and expanding exports. Additionally, government initiatives promoting nutrition and wellness further stimulate growth, making Asia Pacific one of the fastest-growing regions in the global Ascorbic Acid market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR by increasing demand from the food and beverage sector, especially for its antioxidant properties and role as a vitamin supplement. Rising health consciousness and the expanding nutraceutical industry contribute to market growth. Key players focus on innovation and sustainable production methods to meet stringent regulations. The pharmaceutical and cosmetic industries also bolster demand. With well-established supply chains and advanced manufacturing facilities, North America maintains a steady market trajectory, supported by consumer preference for natural and fortified products.
Key players in the market
Some of the key players profiled in the Ascorbic Acid Market include BASF, CSPC Weisheng Pharmaceutical, Honson Pharmatech Group, Microvi Biotech Inc., MEDISCA, Reckon Organics Pvt. Ltd., DSM Nutritional Products, Anhui Minmetals Development Co., Ltd., Northeast Pharmaceutical Group Co., Ltd., Hebei Welcome Pharmaceutical Co., Ltd., Zhejiang NHU Co., Ltd., Wuhan NHU Co., Ltd., FINE USA, Inc., Zhejian Medicine Co., Ltd., Shijiazhuang No.4 Pharmaceutical Co., Ltd., Wuhan Zhongxin Biological Pharmaceutical Co., Ltd., Hangzhou Hestar Biotech Co., Ltd. and Zhucheng Tongda Chemical Co., Ltd.
In November 2024, BASF partnered with Acies Bio to develop sustainable fermentation technologies for producing fatty alcohols, essential in personal and home care products. This collaboration aims to utilize Acies Bio's OneCarbonBio platform for efficient conversion of renewable methanol into chemical raw materials.
In January 2024, CSPC Innovation Pharmaceutical Co., Ltd. agreed to acquire CSPC Baike Biopharmaceutical Co., Ltd. from CSPC Weisheng Pharmaceutical and other CSPC entities for CNY 9.8 billion. This deal was aimed at consolidating CSPC's innovative drug pipeline and strengthening its core business, including health food and functional raw materials, which are closely tied to the ascorbic acid market